We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Innovative Device Measures Glucose in Saliva for More Convenient Diabetes Monitoring

By LabMedica International staff writers
Posted on 30 Aug 2023
Print article
Image: The new sensor can measure glucose levels in saliva (Photo courtesy of KAUST)
Image: The new sensor can measure glucose levels in saliva (Photo courtesy of KAUST)

Diabetes arises when the body fails to regulate its blood glucose levels. Elevated glucose levels can lead to cardiovascular disease and other ailments, making it essential for individuals with diabetes to keep their blood glucose within moderate ranges. The conventional method for monitoring blood glucose in people with diabetes involves using devices that analyze a droplet of blood obtained through finger pricking multiple times daily. Recently, implanted sensors have enabled continuous glucose monitoring without the discomfort of pinpricks, but these devices might be less accurate for lower glucose levels and are not approved for children. A more convenient alternative could be salivary testing, as saliva correlates with blood glucose levels. However, glucose concentrations in saliva are much lower than in blood, posing challenges for accurate measurement without advanced laboratory equipment.

Researchers at King Abdullah University of Science and Technology (KAUST, Saudi Arabia) have now created a prototype sensor capable of measuring glucose levels in saliva. This innovation could eventually offer a simple, swift, and painless way for individuals to monitor their diabetes. The KAUST team devised a remarkably sensitive glucose detector built on a thin-film transistor. These compact, lightweight, and energy-efficient devices could be produced en masse as affordable disposable sensors. The transistor features thin layers of semiconductors, including indium oxide and zinc oxide, along with the enzyme glucose oxidase on top. When a saliva sample is applied to the sensor, the enzyme converts any glucose present into D-gluconolactone and hydrogen peroxide. The electrical oxidation of hydrogen peroxide generates electrons that enter the semiconductor layers, modifying the current flowing through the semiconductors. This change reflects the glucose concentration in the sample.

The researchers evaluated their device using human saliva samples with varying glucose levels and also analyzed saliva from fasting volunteers (since saliva glucose levels might not align with blood glucose levels immediately after eating). They discovered that the device accurately measured a broad range of glucose concentrations in under a minute. Importantly, the sensor remained unaffected by other molecules in saliva, including sugar derivatives like fructose and sucrose. Although the device's sensitivity decreased over time, it maintained good performance even after two weeks of storage at room temperature. The team is presently working on an array of transistor sensors that could simultaneously detect multiple metabolites in saliva.

“An easy-to-use noninvasive glucose-measuring device using saliva as a medium could be life-changing for millions of patients worldwide,” said research team member Abhinav Sharma.

“The development of portable sensor arrays that can be integrated with a smartphone is a potential future direction for research,” added Thomas Anthopoulos, who led the research team.

Related Links:
KAUST 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.